Workflow
凯龙股份(002783) - 2023 Q1 - 季度财报
KAILONGKAILONG(SZ:002783)2023-04-14 16:00

Financial Performance - The company's revenue for Q1 2023 was ¥784.31 million, representing a 14.17% increase compared to ¥686.97 million in the same period last year[5]. - Net profit attributable to shareholders decreased by 55.36% to ¥29.35 million from ¥65.74 million year-on-year[5]. - The net profit after deducting non-recurring gains and losses increased by 142.83% to ¥22.82 million from ¥9.40 million in the previous year[5]. - Total operating revenue for Q1 2023 was CNY 784,306,846.55, an increase of 14.2% compared to CNY 686,973,446.60 in Q1 2022[18]. - Net profit for Q1 2023 was CNY 38,180,137.66, a decrease of 46.3% from CNY 70,975,199.66 in Q1 2022[19]. - Basic and diluted earnings per share for Q1 2023 were CNY 0.0751, down from CNY 0.1722 in Q1 2022, a decline of 56.4%[20]. - The company's total equity increased to CNY 2,365,215,743.83 in Q1 2023, compared to CNY 2,255,596,773.43 in Q1 2022, reflecting a growth of 4.9%[19]. - The company reported a decrease in tax expenses to CNY 6,923,857.04 in Q1 2023 from CNY 18,567,460.46 in Q1 2022, a decline of 62.7%[19]. - Other comprehensive income after tax for Q1 2023 was CNY -42,840.00, compared to CNY -1,071,000.00 in Q1 2022[20]. Cash Flow and Assets - The net cash flow from operating activities dropped by 55.55% to ¥41.72 million compared to ¥93.86 million in the same period last year[5]. - Cash received from sales of goods and services in Q1 2023 was CNY 909,222,931.46, an increase of 48.0% from CNY 614,483,687.43 in Q1 2022[22]. - Operating cash inflow totaled CNY 954,527,865.70, an increase of 48% compared to CNY 644,681,453.07 in the previous year[23]. - Net cash flow from operating activities was CNY 41,722,271.70, down 56% from CNY 93,861,510.22 year-over-year[23]. - Investment cash outflow amounted to CNY 267,965,109.04, up 31% from CNY 204,636,919.46 in the same period last year[23]. - Net cash flow from investment activities was negative CNY 238,450,583.44, worsening from negative CNY 101,770,882.66 year-over-year[23]. - Financing cash inflow reached CNY 638,677,000.96, an increase of 19% compared to CNY 534,147,000.00 in the previous year[23]. - Net cash flow from financing activities was CNY 114,802,899.72, significantly up from CNY 35,757,869.76 year-over-year[23]. - The total cash and cash equivalents at the end of the period stood at CNY 644,978,051.19, compared to CNY 533,965,633.96 at the end of the previous year[23]. - The company reported a cash outflow of CNY 81,982,937.89 for the quarter, contrasting with an inflow of CNY 27,848,497.32 in the same quarter last year[23]. Assets and Liabilities - Total assets at the end of the reporting period were ¥7.40 billion, a decrease of 0.82% from ¥7.46 billion at the end of the previous year[5]. - Current assets decreased to RMB 2,375,128,708.82 from RMB 2,574,772,842.21 at the beginning of the year, primarily due to a reduction in cash and cash equivalents[15]. - The company's cash and cash equivalents stood at RMB 728,525,284.21, down from RMB 991,208,915.62 at the beginning of the year, reflecting a decrease of approximately 26.5%[15]. - Short-term borrowings increased to RMB 1,456,111,722.22 from RMB 1,390,697,059.72, indicating a rise of about 4.7%[15]. - Accounts receivable rose to RMB 603,408,290.64 from RMB 549,513,270.53, marking an increase of approximately 9.8%[15]. - Inventory increased to RMB 435,928,049.30 from RMB 387,079,889.51, reflecting a growth of about 12.5%[15]. - The company reported a significant increase in prepayments, which rose to RMB 100,852,701.38 from RMB 48,250,671.34, an increase of approximately 108.7%[15]. - The company’s long-term equity investments slightly increased to RMB 225,376,477.37 from RMB 224,094,639.26, showing a marginal growth[15]. - Total liabilities decreased to CNY 5,036,529,301.25 in Q1 2023 from CNY 5,207,460,293.99 in Q1 2022, a reduction of 3.3%[19]. Research and Development - R&D expenses increased by 52.87% to ¥17.66 million, driven by higher investment in research projects[8]. - The company's R&D expenses increased to CNY 17,581,673.72 in Q1 2023, compared to CNY 11,501,411.09 in Q1 2022, marking a growth of 53.0%[19]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 25,183[10]. - The top shareholder, Zhongjing Investment Holdings Group Co., Ltd., holds 15.29% of the shares, with 59,792,682 shares pledged[10]. Future Plans - The company plans to raise up to RMB 850 million through a private placement of A-shares to fund projects including the technological transformation of electronic detonator production lines and the construction of a fine chemical limestone production line with an annual capacity of 5 million tons[12]. - The company is undergoing a technological upgrade in its production lines to enhance efficiency and output capacity[12].